US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
State Street SPDR S&P Pharmaceuticals ETF
(NY:
XPH
)
63.64
-0.14 (-0.22%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about State Street SPDR S&P Pharmaceuticals ETF
< Previous
1
2
3
Next >
Pharma ETFs in Focus Post Q1 Earnings
↗
May 12, 2021
The slew of Q1 results has led to mixed trading in pharma ETFs over the past month. Here are those in detail.
Via
Talk Markets
3 Pharmaceutical ETFs That Could Be Due For A Rebound
↗
April 15, 2021
Here are three pharmaceutical ETFs have dropped to support, which means they may be about to rebound.
Via
Talk Markets
3 Pharmaceutical ETFs That Could Be Due For A Rebound
↗
April 15, 2021
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of bu...
Via
Benzinga
< Previous
1
2
3
Next >